Hélène Aschmann M.Sc., studied Medicinal and Industrial Pharmaceutical
Sciences at ETH Zurich. She performed her master thesis at RWTH Aachen on physiologically-based pharmacokinetic and pharmacodynamic (PBPK/PD) modeling.
In April 2016 she joined the Epidemiology, Biostatistics, and Prevention Institute as a PhD candidate under the supervision of Prof. Dr. Milo Puhan. Her research focuses on benefit-harm assessments in hypertension and diabetes.